Related Experiment Video
Updated: May 28, 2026

Ocular Therapeutic Delivery and Advanced Tissue Retrieval in Adult Rats
Published on: May 23, 2025
Treatment with Cyclophosphamide for steroid-resistant nephrotic syndrome in children
Florentina Cucer1, Ingrith Miron, Robert Müller
1IV Clinic of Pediatrics, "Gr.T. Popa" University of Medicine and Pharmacy, Iasi, Romania.
Abstract:
The management of patients with steroid-resistant nephrotic syndrome remains difficult. We repport our experience with Cyclophosphamide therapy, in an attempt to compare the results between an oral protocol and two i.v. protocols. The complete and sustained general remission rate was 43.1%, which confirms the efficacy of the treatment, especially for children with minimal change nephrotic syndrome. For the i.v. administration we recommend only 6 month of therapy, due to severe side-effects in longer courses.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Nephrotic Syndrome III : Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome I : Introduction